Objective: To report the prevalence of Gardnerella, Trichomonas and Candida in the cervical smears of 9 immigrant groups participating in the Dutch national cervical screening program. Study Design: Cervical smears were taken from 58,904 immigrant participants and 498,405 Dutch participants. As part of the routine screening process, all smears were screened for the overgrowth of Gardnerella (i.e. smears with an abundance of clue cells) and for the presence of Trichomonas and Candida. The smears were screened by 6 laboratories, all of which use the Dutch KOPAC coding system. The odds ratio and confidence interval were calculated for the 9 immigrant groups and compared to Dutch participants. Results: Immigrants from Suriname, Turkey and the Dutch Antilles have a 2–5 times higher prevalence of Gardnerella and Trichomonas when compared to native Dutch women. Interestingly, the prevalence of Trichomonas in cervical smears of Moroccan immigrants is twice as high, yet the prevalence of Gardnerella is 3 times lower than in native Dutch women. Conclusions: Immigrants with a high prevalence of Gardnerella also have a high prevalence of Trichomonas. In the context of the increased risk of squamous abnormalities in smears with Gardnerella, such slides should be screened with extra care.

Keywords:
Trichomonas, Candida, Cervical smear, Gardnerella
1.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative: Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806–808.
2.
Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ: The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004;57:388–393.
3.
Boon ME, van Ravenswaay Claasen HH, van Westering RP, Kok LP: Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix. Cancer 2003;99:4–8.
4.
Engberts MK, Vermeulen CFW, Verbruggen BSM, Haaften M van, Boon ME, Heintz AP: Candida and squamous (pre)neoplasia of immigrants and Dutch women as established in population-based cervical screening. Int J Gynecol Cancer 2006;16:1596–1600.
5.
Engberts MK, Verbruggen BS, Boon ME, van Haaften M, Heintz AP: Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. Cancer 2007;111:269–274.
6.
Engberts MK, Boon ME, van Haaften M, Heintz AP: Symptomatic candidiasis: using self-sampled vaginal smears to establish the presence of Candida, Lactobacilli, and Gardnerella vaginalis. Diagn Cytopathol 2007;35:635–639.
7.
Klomp JM, Boon ME, van Haaften M, Heintz AP: Cytologically diagnosed Gardnerella vaginalis infection and cervical (pre)neoplasia as established in population-based cervical screening. Am J Obstet Gynecol 2008;199:480–485.
8.
Klomp JM, Ouwerkerk-Noordam E, Boon ME, van Haaften M, Heintz AP: Gardnerella infection as distinguished from cervical dysbacteriosis: the advantageous spin-off of cervical screening. Acta Cytol 2009;53:389–395.
9.
Boon ME, Boon LM, de Bosschere MJ, Verbruggen BSM, Kok LP: Koilocytosis and squamous (pre)neoplasia as detected in population-based cervical screening: practice and theory. Eur J Gynaecol Oncol 2005;26:533–536. Eur J Gyn Oncol 2005;26:533–536.
10.
Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001;10:1021–1027.
11.
Klomp JM, Boon ME, Dorman MZ, van Haaften M, Heintz AP: Trends in inflammatory status of the vaginal flora as established in the Dutch national screening program for cervical cancer over the last decade. Acta Cytol 2010;54:43–49.
12.
Roeters AM, Boon ME, van Haaften M, Vernooij F, Bontekoe TjR, Heintz APM: Inflammatory events as detected in cervical smears and squamous intraepithelial lesions. Diagn Cytopathol 2010;38:85–93.
13.
Verbruggen BS, Boon ME, Boon LM: Dysbacteriosis and squamous (pre)neoplasia of immigrants and Dutch women as established in population-based cervical screening. Diagn Cytopathol 2006;34:377–381.
14.
Statistics Netherlands (Centraal Bureau voor de Statistiek), The Hague/Heerlen, StatLine database. www.cbs.nl.
15.
Bland JM, Altman DG: Statistics notes. The odds ratio. BMJ 2000;320:1468.
16.
Vermeulen CF, Grünberg A, Peters LA, van der Linden-Narain IB, Vrede MA, Krul EJ, Dekker FW, Fleuren GJ: Ethnic patterns of cytologic abnormalities in cervical smears in suriname, a high-risk area for cervical cancer. Acta Cytol 2006;50:621–626.
17.
Klomp JM, Verbruggen BS, Korporaal H, Boon ME, Jong P de, Kramer GC, Haaften M van, Heintz AP: Gardnerella vaginalis and Lactobacillus sp in liquid-based cervical samples in healthy and disturbed vaginal flora using cultivation-independent methods. Diagn Cytopathol 2008;36:277–284.
18.
Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M: The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 2010;10:81.
19.
van Andel T, de Korte S, Koopmans D, Behari-Ramdas J, Ruysschaert S: Dry sex in Suriname. J Ethnopharmacol 2008;116:84–88.
20.
Guaschino S, Benvenuti C, SOPHY Study Group: SOPHY project: an observational study of vaginal pH, lifestyle and correct intimate hygiene in women of different ages and in different physiopathological conditions. II. Minerva Ginecol 2008;60:353–362.
21.
Guaschino S, Benvenuti C; SOPHY Study Group: SOPHY project: an observational study of vaginal pH and lifestyle in women of different ages and in different physiopathological conditions. I. Minerva Ginecol 2008;60:105–114.
22.
Fiorilli A, Molteni B, Milani M: Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 2005;120:202–205.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.